Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 3Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2FED 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 21Neoplasm Metastasis 3Sleep Initiation and Maintenance Disorders 1Prostatic Diseases 1Prostate Cancer Metastatic Disease 1Neoadjuvant Therapy 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1High Risk Prostate Cancer 1Hematologic Neoplasms 1Genital Diseases, Male 1Fatigue 1Depression 1Adenocarcinoma 1

Interventions

pembrolizumab 49Specimen Handling 29Magnetic Resonance Spectroscopy 25Biopsy 25Radiosurgery 17Gemcitabine 17Nivolumab 16Cyclophosphamide 14Cisplatin 14Paclitaxel 13Carboplatin 13Bevacizumab 13Leucovorin 11Irinotecan 11Fluorouracil 11Drug Therapy 11Taxes 10Radiotherapy 10Oxaliplatin 10Capecitabine 10trastuzumab deruxtecan 9fludarabine 9cemiplimab 8Doxorubicin 8Cetuximab 8abemaciclib 7Trastuzumab 7Pemetrexed 7Fulvestrant 7Docetaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Metastasis × apalutamide × Clear all
NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting
464 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06652607 2025-03-12

PSA-DEEP02

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
152 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06473259 2024-06-25

ECHOS

Santa Chiara Hospital

Recruiting
3,000 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡